Contact Us
Pulmonary Drug Delivery Devices Global Market Report 2025
Global Pulmonary Drug Delivery Devices Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Pulmonary Drug Delivery Devices Global Market Report 2025

By Product Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), By Application (Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-Commerce) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pulmonary Drug Delivery Devices Market Overview

• Pulmonary Drug Delivery Devices market size has reached to $49.52 billion in 2024

• Expected to grow to $68.18 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%

• Growth Driver: Escalating Prevalence Of Respiratory Disorders Is Driving Factors Behind The Growth Of The Pulmonary Drug Delivery Devices Market

• Market Trend: Innovation In Pulmonary Drug Delivery Devices

North America was the largest region in 2024.

What Is Covered Under Pulmonary Drug Delivery Devices Market?

Pulmonary drug delivery devices are inhalation devices used to deliver medications directly to the lungs. These devices allow for targeted delivery of drugs to treat respiratory diseases like asthma and Chronic Obstructive Pulmonary Disease (COPD). Pulmonary delivery also enables systemic absorption of drugs like insulin and pain medications.

The main product types of pulmonary drug delivery devices included are dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers are devices that deliver a measured dose of medication in the form of a fine, dry powder that the patient inhales directly into their lungs. It is provided for applications such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and others and is sold through distribution channels such as retail pharmacies, hospital pharmacies, and E-Commerce.

Pulmonary Drug Delivery Devices Market Size and growth rate 2025 to 2029: Graph

What Is The Pulmonary Drug Delivery Devices Market Size 2025 And Growth Rate?

The pulmonary drug delivery devices market size has grown strongly in recent years. It will grow from $49.52 billion in 2024 to $52.8 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, the growing aging population worldwide, rising awareness about the importance of respiratory health, expansion of healthcare expenditure in emerging economies, and increasing adoption of homecare settings for respiratory therapy.

What Is The Pulmonary Drug Delivery Devices Market Growth Forecast?

The pulmonary drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $68.18 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to the growing demand for personalized and precision medicine in respiratory care, expansion of home healthcare services and remote patient monitoring, rising investments in research and development, and increasing focus on preventive healthcare and early intervention strategies. Major trends in the forecast period include technological innovations, the shift towards value-based care models and patient-centric approaches, the integration of telehealth and remote monitoring capabilities into respiratory therapy platforms, the utilization of wearables and mobile applications for self-management of respiratory conditions, and the adoption of 3D printing and digital manufacturing techniques.

The forecast of 6.6% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased tariffs on vibrating mesh nebulizer plates and dose-counting mechanisms, mainly imported from the UK and South Korea, raising costs for respiratory medication administration.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Pulmonary Drug Delivery Devices Market Segmented?

1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers

2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce

Subsegments:

1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs

2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs

3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers

What Is Driving The Pulmonary Drug Delivery Devices Market? Escalating Prevalence Of Respiratory Disorders Is Driving Factors Behind The Growth Of The Pulmonary Drug Delivery Devices Market

The escalating prevalence of respiratory disorders is expected to propel the growth of the pulmonary drug delivery devices market going forward. Respiratory disorders refer to diseases or conditions that affect the lungs and airways, impacting human respiration. There is an increasing prevalence of respiratory disorders due to several factors such as rising levels of air pollution, increasing smoking rates, urbanization, climate change, and the aging population. Pulmonary drug delivery devices play an important role in the treatment of respiratory disorders by allowing direct delivery of medications to the lungs. For instance, in May 2024, according to the Centers for Disease Control And Prevention (CDC), a US-based national public health agency, the prevalence of current asthma among adults aged 18 and over, increasing from 8.0 % in 2021 to 8.7% in 2022. Therefore, the escalating prevalence of respiratory disorders is expected to propel the growth of the pulmonary drug delivery devices industry.

Who Are The Major Players In The Global Pulmonary Drug Delivery Devices Market?

Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.

What Are The Key Trends Of The Global Pulmonary Drug Delivery Devices Market? Innovation In Pulmonary Drug Delivery Devices

Major companies operating in the pulmonary drug delivery devices market are developing innovative products, such as small-volume nebulizers, to better serve customers with advanced features. A small-volume nebulizer (SVN) is a medical device used to deliver liquid medication in the form of aerosolized mist to patients with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. For instance, in May 2024, Medline Industries LP, a US-based healthcare company, launched the Hudson RCI TurboMist small-volume nebulizer. This groundbreaking device is designed to deliver medication treatments quickly, in as little as three minutes. The innovative nebulizer can dispense 2.5 times more medication per minute compared to standard nebulizers, reducing treatment times by about 70%. This increase in medication delivery significantly reduces treatment times, benefiting healthcare providers by optimizing patient throughput and enhancing the patient experience by shortening the duration of therapy sessions.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Pulmonary Drug Delivery Devices Market? Sandoz Group AG Acquires Coalesce Product Development Limited To Enhance Respiratory Medicine Portfolio

In August 2022, Sandoz Group AG., a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. Through this acquisition, Sandoz aims to strengthen its portfolio of respiratory medicines and improve patient access to high-quality, complex therapies. Coalesce Product Development Limited is a UK-based company that provides pulmonary drug delivery devices.

What Is The Regional Outlook For The Global Pulmonary Drug Delivery Devices Market?

North America was the largest region in the pulmonary drug delivery devices market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pulmonary Drug Delivery Devices Market?

The pulmonary drug delivery devices market consists of sales of jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pulmonary Drug Delivery Devices Industry?

The pulmonary drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary drug delivery devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Pulmonary Drug Delivery Devices Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $52.8 billion
Revenue Forecast In 2034 $68.18 billion
Growth Rate CAGR of 6.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce Subsegments: 1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Pulmonary Drug Delivery Devices Market Characteristics

3. Pulmonary Drug Delivery Devices Market Trends And Strategies

4. Pulmonary Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pulmonary Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

5.1. Global Pulmonary Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pulmonary Drug Delivery Devices Market Growth Rate Analysis

5.4. Global Pulmonary Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pulmonary Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pulmonary Drug Delivery Devices Total Addressable Market (TAM)

6. Pulmonary Drug Delivery Devices Market Segmentation

6.1. Global Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dry Powder Inhalers

Metered Dose Inhalers

Nebulizers

6.2. Global Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Asthma

Cystic Fibrosis

Chronic Obstructive Pulmonary Disease

Other Applications

6.3. Global Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Retail Pharmacies

Hospital Pharmacies

E-Commerce

6.4. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Dry Powder Inhalers (DPIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single-Dose DPIs

Multi-Dose DPIs

6.5. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Metered Dose Inhalers (MDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CFC-Based MDIs

HFA-Based MDIs

6.6. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Jet Nebulizers

Ultrasonic Nebulizers

Mesh Nebulizers

7. Pulmonary Drug Delivery Devices Market Regional And Country Analysis

7.1. Global Pulmonary Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pulmonary Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pulmonary Drug Delivery Devices Market

8.1. Asia-Pacific Pulmonary Drug Delivery Devices Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pulmonary Drug Delivery Devices Market

9.1. China Pulmonary Drug Delivery Devices Market Overview

9.2. China Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pulmonary Drug Delivery Devices Market

10.1. India Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pulmonary Drug Delivery Devices Market

11.1. Japan Pulmonary Drug Delivery Devices Market Overview

11.2. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pulmonary Drug Delivery Devices Market

12.1. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pulmonary Drug Delivery Devices Market

13.1. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pulmonary Drug Delivery Devices Market

14.1. South Korea Pulmonary Drug Delivery Devices Market Overview

14.2. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pulmonary Drug Delivery Devices Market

15.1. Western Europe Pulmonary Drug Delivery Devices Market Overview

15.2. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pulmonary Drug Delivery Devices Market

16.1. UK Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pulmonary Drug Delivery Devices Market

17.1. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pulmonary Drug Delivery Devices Market

18.1. France Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pulmonary Drug Delivery Devices Market

19.1. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pulmonary Drug Delivery Devices Market

20.1. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pulmonary Drug Delivery Devices Market

21.1. Eastern Europe Pulmonary Drug Delivery Devices Market Overview

21.2. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pulmonary Drug Delivery Devices Market

22.1. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pulmonary Drug Delivery Devices Market

23.1. North America Pulmonary Drug Delivery Devices Market Overview

23.2. North America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pulmonary Drug Delivery Devices Market

24.1. USA Pulmonary Drug Delivery Devices Market Overview

24.2. USA Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pulmonary Drug Delivery Devices Market

25.1. Canada Pulmonary Drug Delivery Devices Market Overview

25.2. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pulmonary Drug Delivery Devices Market

26.1. South America Pulmonary Drug Delivery Devices Market Overview

26.2. South America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pulmonary Drug Delivery Devices Market

27.1. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pulmonary Drug Delivery Devices Market

28.1. Middle East Pulmonary Drug Delivery Devices Market Overview

28.2. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pulmonary Drug Delivery Devices Market

29.1. Africa Pulmonary Drug Delivery Devices Market Overview

29.2. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pulmonary Drug Delivery Devices Market Competitive Landscape And Company Profiles

30.1. Pulmonary Drug Delivery Devices Market Competitive Landscape

30.2. Pulmonary Drug Delivery Devices Market Company Profiles

30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Air Liquide S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pulmonary Drug Delivery Devices Market Other Major And Innovative Companies

31.1. ResMed Inc.

31.2. Drägerwerk AG And Co. KGaA

31.3. Smiths Group plc

31.4. AptarGroup Inc.

31.5. Chiesi Farmaceutici S.p.A.

31.6. Teleflex Incorporated

31.7. Masimo Corporation

31.8. Fisher And Paykel Healthcare Limited

31.9. Invacare Corporation

31.10. Vyaire Medical Inc.

31.11. Inogen Inc.

31.12. Drive DeVilbiss Healthcare Inc.

31.13. Hovione

31.14. Hamilton Medical AG

31.15. GaleMed Corporation

32. Global Pulmonary Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pulmonary Drug Delivery Devices Market

34. Recent Developments In The Pulmonary Drug Delivery Devices Market

35. Pulmonary Drug Delivery Devices Market High Potential Countries, Segments and Strategies

35.1 Pulmonary Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities

35.2 Pulmonary Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities

35.3 Pulmonary Drug Delivery Devices Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Dry Powder Inhalers (DPIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Metered Dose Inhalers (MDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Pulmonary Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Pulmonary Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Medtronic plc Financial Performance
  • Table 78: Air Liquide S.A. Financial Performance
  • Table 79: Becton Dickinson and Company Financial Performance
  • Table 80: Koninklijke Philips N.V. Financial Performance
  • Table 81: Medline Industries Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Dry Powder Inhalers (DPIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Metered Dose Inhalers (MDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Pulmonary Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Pulmonary Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Medtronic plc Financial Performance
  • Figure 78: Air Liquide S.A. Financial Performance
  • Figure 79: Becton Dickinson and Company Financial Performance
  • Figure 80: Koninklijke Philips N.V. Financial Performance
  • Figure 81: Medline Industries Inc. Financial Performance

Frequently Asked Questions

Pulmonary drug delivery devices are inhalation devices used to deliver medications directly to the lungs. These devices allow for targeted delivery of drugs to treat respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). Pulmonary delivery also enables systemic absorption of drugs like insulin and pain medications. For further insights on this market, request a sample here

The market major growth driver - Escalating Prevalence Of Respiratory Disorders Is Driving Factors Behind The Growth Of The Pulmonary Drug Delivery Devices Market. For further insights on this market, request a sample here

The pulmonary drug delivery devices market size has grown strongly in recent years. It will grow from $49.52 billion in 2024 to $52.8 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, the growing aging population worldwide, rising awareness about the importance of respiratory health, expansion of healthcare expenditure in emerging economies, and increasing adoption of homecare settings for respiratory therapy. The pulmonary drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $68.18 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to the growing demand for personalized and precision medicine in respiratory care, expansion of home healthcare services and remote patient monitoring, rising investments in research and development, and increasing focus on preventive healthcare and early intervention strategies. Major trends in the forecast period include technological innovations, the shift towards value-based care models and patient-centric approaches, the integration of telehealth and remote monitoring capabilities into respiratory therapy platforms, the utilization of wearables and mobile applications for self-management of respiratory conditions, and the adoption of 3D printing and digital manufacturing techniques. For further insights on this market, request a sample here

The pulmonary drug delivery devicesmarket covered in this report is segmented –
1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce Subsegments:
1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers For further insights on this market,
request a sample here

North America was the largest region in the pulmonary drug delivery devices market in 2024. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.. For further insights on this market, request a sample here.

Major trends in this market include Innovation In Pulmonary Drug Delivery Devices. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon